Impact of Simeprevir Versus Telaprevir Triple Therapy for Chronic Hcv Infection on Patient-Reported Outcomes in Prior Non-Responders to Peginterferon/Ribavirin Results from the Phase Iii Attain Study

Nov 1, 2014, 00:00
10.1016/j.jval.2014.08.2543
https://www.valueinhealthjournal.com/article/S1098-3015(14)04473-8/fulltext
Title : Impact of Simeprevir Versus Telaprevir Triple Therapy for Chronic Hcv Infection on Patient-Reported Outcomes in Prior Non-Responders to Peginterferon/Ribavirin Results from the Phase Iii Attain Study
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(14)04473-8&doi=10.1016/j.jval.2014.08.2543
First page : A682
Section Title : Disease-Specific Studies
Open access? : No
Section Order : 1996
Categories :
Tags :
Regions :
ViH Article Tags :